NUSTENDI cpr pell 180/10 mg 28 pce

7680675860012 CH-67586 C10B 07.12.0.

Reimbursement limitations:

NUSTENDI.01

NUSTENDI est remboursé :
- en combinaison avec une statine
- seul en cas d'intolérance …

NUSTENDI cpr pell 180/10 mg 28 pce
NUSTENDI cpr pell 180/10 mg 28 pce
NUSTENDI cpr pell 180/10 mg 28 pce
1 / 3
google

Details

Product number
6758601
CPT
-
Packaging group
28
Unit
mg
Composition
ezetimibum 10 mg, acidum bempedoicum 180 mg, lactosum monohydricum 75 mg, cellulosum microcristallinum, carboxymethylamylum natricum, povidonum K 30, natrii laurilsulfas, silica colloidalis anhydrica, hydroxypropylcellulosum, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, E 171, E 132, glyceroli monocaprylocapras, natrii laurilsulfas, E 133, pro compresso obducto corresp. natrium 1.38 mg.

Articles (1)

Nustendi 180 mg / 10 mg, Filmtabletten
Filmtabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/08/2025
Patient information leaflet
Français
13/08/2025
Patient information leaflet
Italien
13/08/2025
Professional SmPC
Allemand
13/08/2025
Professional SmPC
Français
13/08/2025
Professional SmPC
Italien
13/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
180.0 MG Substance Wirkstoff (Principe actif)
(N/A)
75.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FIMDK
(N/A)
1.38 MG Substance HBESI

Reimbursement information

Public price
CHF 77.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2022

Authorization holder

Daiichi Sankyo (Schweiz) AG

8048 Zürich

Authorization information

Swissmedic authorization number
67586
Drug name
Nustendi, Filmtabletten
Galenic form
FILM
ATC Code
C10BA10
Authorization status
Z
Dispensation category
B
First authorization
15/12/2020
Authorization expiration date
31/12/9999
IT number
07.12.0.
Domain
Human medicine
Field of application
Primäre Hypercholesterinämie (heterozygot familiär und nicht familiär) oder gemischte Dyslipidämie sowie Reduktion des kardiovaskulären Risikos.

Packaging details

Description (FR)
NUSTENDI cpr pell 180/10 mg 28 pce
Description (DE)
NUSTENDI Filmtabl 180/10 mg 28 Stk
Market launch
15/12/2020
Narcotic (BTM)
No

Other packaging sizes

NUSTENDI cpr pell 180/10 mg 98 pce
98 MG
View